A $10 million donation will fund five years of Yale research into preventing or reversing type 1 diabetes, a condition that requires daily insulin and affects millions of people worldwide.
Anastasia and Igor Bukhman made the gift through the Bukhman Foundation, Yale School of Medicine said. The program brings together researchers studying immune responses and insulin-producing cells to develop approaches tailored to individual patients.
Kevan Herold, C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology), leads the work. The team plans to map patients’ immune profiles, develop humanized mouse models for individual patients, investigate why immune tolerance breaks down and find ways to help replacement beta cells survive and function.
Yale said the patient-specific models build on 25 years of mouse-genetics research at the school. Other researchers involved include Esen Sefik, Richard Flavell, Nikhil Joshi, Richard Kibbey and John Tsang, whose work spans immunology, disease modeling, beta-cell biology and computational analysis.
The research addresses both the immune damage to beta cells and the loss of cells that produce insulin. Herold said the program’s aim is “the prevention or reversal of disease.” Yale described research goals, but gave no timetable for clinical trials or expected results.
The World Health Organization estimated about 9.5 million people were living with type 1 diabetes in 2025, with more than 500,000 new cases diagnosed that year. The agency says the disease’s cause and ways to prevent it remain unknown.


